CSPC Pharmaceutical Group Limited (HKG:1093)

CSPC Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	56,824	86,022	97,707	100,932	94,800	115,871
Market Cap Growth	3.68%	-11.96%	-3.19%	6.47%	-18.19%	64.42%
Enterprise Value	50,465	74,600	84,557	88,212	87,594	111,142
Last Close Price	4.94	6.92	7.51	7.56	6.97	8.36
PE Ratio	12.59	13.30	14.19	14.67	15.47	27.89
Forward PE	10.80	12.05	13.86	15.70	15.49	23.49
PS Ratio	1.88	2.48	2.79	2.95	3.20	4.69
PB Ratio	1.66	2.23	2.73	3.07	3.46	5.31
P/TBV Ratio	1.97	2.53	3.08	3.24	3.68	6.04
P/FCF Ratio	30.56	15.99	25.49	14.83	54.49
P/OCF Ratio	18.68	11.33	17.73	11.84	27.37
PEG Ratio	1.83	1.25	1.25	1.25	1.03	1.08
EV/Sales Ratio	1.63	2.15	2.42	2.58	2.96	4.50
EV/EBITDA Ratio	7.65	8.53	9.83	10.31	11.98	19.67
EV/EBIT Ratio	8.99	9.65	11.07	11.50	13.48	22.33
EV/FCF Ratio	26.50	13.83	22.27	13.70	52.26
Debt / Equity Ratio	0.01	0.02	0.02	0.00	0.01	0.01
Debt / EBITDA Ratio	0.05	0.09	0.08	0.01	0.05	0.04
Debt / FCF Ratio	-	0.28	0.11	0.03	0.06	0.10
Asset Turnover	-	0.71	0.81	0.86	0.89	0.89
Inventory Turnover	-	3.26	3.45	3.10	2.85	2.16
Quick Ratio	-	2.32	2.39	2.47	2.22	1.70
Current Ratio	-	2.63	2.67	2.81	2.53	2.20
Return on Equity (ROE)	-	18.22%	21.32%	22.79%	24.54%	21.30%
Return on Assets (ROA)	-	9.96%	11.04%	12.05%	12.13%	11.23%
Return on Capital (ROIC)	-	12.91%	14.29%	15.52%	15.86%	15.74%
Return on Capital Employed (ROCE)	-	19.40%	20.60%	22.70%	23.00%	22.20%
Earnings Yield	8.11%	7.52%	7.05%	6.82%	6.46%	3.59%
FCF Yield	3.27%	6.26%	3.92%	6.74%	1.84%
Dividend Yield	5.26%	4.04%	2.88%	2.47%	1.83%	1.27%
Payout Ratio	0.00%	46.42%	34.42%	30.16%	29.61%	25.99%
Buyback Yield / Dilution	0.68%	0.38%	0.29%	0.01%	0.00%	0.24%
Total Shareholder Return	5.95%	4.43%	3.17%	2.48%	1.83%	1.51%

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.